News
Medical Device Network on MSN3d
Epiminder’s implantable EEG system for epilepsy receives FDA authorisationAustralia-based company Epiminder has received Food and Drug Administration (FDA) authorisation through the De Novo classification for its implantable continuous electroencephalogram (EEG) monitoring ...
Epiminder noted that the Minder system addresses the limitations of existing EEG technologies by offering actionable diagnostic information, which is crucial for the management of epilepsy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback